Page 164 - Read Online

J Neurol 2015;262:1859-66. antibody encephalitis: value of immunomodulatory therapy. Arch
47. Finke C, Kopp UA, Prüss H, Dalmau J, Wandinger KP, Ploner CJ. Pediatr 2014;21:620-3.
Cognitive deficits following anti-NMDA receptor encephalitis. J 55. Dale RC, Pillai S, Brilot F. Cerebrospinal fluid CD19(+) B-cell
Neurol Neurosurg Psychiatry 2012;83:195-8. expansion in N-methyl-D-aspartate receptor encephalitis. Dev Med
48. Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Child Neurol 2013;55:191-3.
Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez 56. Mohammad SS, Jones H, Hong M, Nosadini M, Sharpe C, Pillai
E, Aguilar E, Gresa-Arribas N,Ryan-Florance N, Torrents A, Saiz SC, Brilot F, Dale RC. Symptomatic treatment of children with anti-
A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J. Treatment NMDAR encephalitis. Dev Med Child Neurol 2016;58:376-84.
and prognostic factors for long-term outcome in patients with anti- 57. Makatsori M, Kiani-Alikhan S, Manson AL, Verma N, Leandro M,
NMDA receptor encephalitis: an observational cohort study. Lancet Gurugama NP, Longhurst HJ, Grigoriadou S, Buckland M, Kanfer
Neurol 2013;12:157-65. E, Hanson S, Ibrahim MA, Grimbacher B, Chee R, Seneviratne SL.
49. Dale RC, Brilot F, Fagan E, Earl J. Cerebrospinal fluid neopterin Hypogammaglobulinaemia after rituximab treatment-incidence
in paediatric neurology: a marker of active central nervous system and outcomes. QJM 2014;107:821-8.
inflammation. Dev Med Child Neurol 2009;51:317-23. 58. Kim SH, Huh SY, Lee SJ, Joung A, Kim HJ. A 5-year follow-up of
50. Leypoldt F, Hoftberger R, Titulaer MJ, Armangue T, Gresa-Arribas rituximab treatment in patients with neuromyelitis optica spectrum
N, Jahn H, Rostásy K, Schlumberger W, Meyer T, Wandinger KP, disorder. JAMA Neurol 2013;70:1110-7.
Rosenfeld MR, Graus F, Dalmau J. Investigations on CXCL13 59. Haberlandt E, Bast T, Ebner A, Holthausen H, Kluger G, Kravljanac
in anti-N-methyl-d-aspartate receptor encephalitis: a potential R, Kröll-Seger J, Kurlemann G, Makowski C, Rostasy K, Tuschen-
biomarker of treatment response. JAMA Neurol 2015;72:180-6. Hofstätter E, Weber G, Vincent A, Bien CG. Limbic encephalitis in
51. Nakahara E, Sakuma H, Kimura-Kuroda J, Shimizu T, Okumura children and adolescents. Arch Dis Child 2011;96:186-91.
A, Hayashi M. A diagnostic approach for identifying anti-neuronal 60. Baysal-Kirac L, Tuzun E, Altindag E, Ekizoglu E, Kinay D, Bilgic
antibodies in children with suspected autoimmune encephalitis. J B, Tekturk P, Baykan B. Are there any specific eeg findings in
Neuroimmunol 2015;285:150-5. autoimmune epilepsies? Clin EEG Neurosci 2016;47:224-34.
52. Armangue T, Santamaria J, Dalmau J. When a serum test overrides 61. Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L,
the clinical assessment. Neurology 2015;84:1379-81. Leypoldt F, Gleichman AJ, Balice-Gordon R, Rosenfeld MR, Lynch
53. Gabilondo I, Saiz A, Galán L, González V, Jadraque R, Sabater D, Graus F, Dalmau J. Antibody titres at diagnosis and during
L, Sans A, Sempere A, Vela A, Villalobos F, Viñals M, Villoslada follow-up of anti-NMDA receptor encephalitis: a retrospective
P, Graus F. Analysis of relapses in anti-NMDAR encephalitis. study. Lancet Neurol 2014;13:167-77.
Neurology 2011;77:996-9. 62. Mehrpooya M, Vaseghi G, Eshraghi A, Eslami N. Delayed
54. Le Moigno L, Ternant D, Paintaud G, Thibault G, Cloarec S, Myocardial Infarction Associated With Rituximab Infusion: a case
Tardieu M, Lagrue E, Castelnau P. N-methyl-D-aspartate receptor report and literature review. Am J Ther 2016;23:e283-7.

Neuroimmunol Neuroinflammation | Volume 3 | July 8, 2016 155